Teneligliptin hydrobromide hydrate

Teneligliptin Hydrobromide Hydrate is used as an oral antidiabetic medication for managing type 2 diabetes mellitus. It works by inhibiting the DPP-4 enzyme, which increases levels of incretin hormones, enhancing insulin secretion and suppressing glucagon release. This helps in lowering blood glucose levels, especially after meals. It is often used alone or in combination with other antidiabetic drugs like metformin. It is grouped under the following drug class(es): DPP-4 inhibitors and Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Tenelia and Teneligliptin HBr Hydrate. Its PubChem CID is 53297474.

CAS No 1572583-29-9
Molecular Formula C44H67Br5N12O3S2
Molecular Weight 1275.7 g/mol
Synonyms [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone;hydrate;pentahydrobromide

Frequently Asked Questions